Table of contents
Lisa A. Snider(National Institutes of Health), Neal R. Swerdlow, Kristi A. Sacco, Jordan B. Hiller, Yansheng Du(Indiana University – Purdue University Indianapolis), Jill M. Hooley(Harvard University), Brigid S. Boland, Marcia J. Slattery(University of Wisconsin–Madison), Susan E. Swedo(Applied Behavioral Research (United States)), Melissa M. Dudas, Stefan Teipel(German Center for Neurodegenerative Diseases), Jennifer C. Vessicchio, Gregory A. Light, Jack G. Modell, Daniel F. Connor, Angelo Termine, Richard Dodel(Philipps University of Marburg), Harald Hampel(Eisai (United States)), Christina Fischer-Schulz, Aisha A. Seyal, Andreas Bergmann, James J. Hudziak(University of Vermont), Staci A. Gruber, Tony P. George, Lorraine Lougee(Seattle Children's Hospital), Joel Ellwanger, Nathalie Richard, Joyce Sprock, Joseph P. Horrigan, Paul Grant, S. Brettschneider, Katharina Bu, Hans-Ju ̈rgen Möller, Nils G. Morgenthaler, David Braff, Deborah Yurgelun‐Todd(Harvard University Press), Laurie Scott, Norman E. Rosenthal, Margaret Fonder, Kenneth D. Hampton, Barbara R. Haight, Timothy E. Wilens(Massachusetts General Hospital)
Cited by 0
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Amyloid-β Pathway in Alzheimer’s Disease
|Molecular Psychiatry|2021|1.8k
Cost of disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|1.7k